» Articles » PMID: 21242521

Proper Regrafting of Ig-like Transcript 2 After Trogocytosis Allows a Functional Cell-cell Transfer of Sensitivity

Overview
Journal J Immunol
Date 2011 Jan 19
PMID 21242521
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The acquisition by T cells of exogenous ligands originally expressed by APC has been already described. However, reports essentially focused on the outward signaling of acquired ligands and their effects on surroundings cells. We investigated the function of transferred receptors (not ligands) on the T cells that acquired them (not on cells they interact with). We show that inhibitory Ig-like transcript 2 receptors efficiently transfer from monocytes to autologous T cells by trogocytosis and integrate within the plasma membrane of the acquirer T cells. Furthermore, the acquired receptors can access compatible signaling machinery within acquirer T cells and use it to signal and alter the functions of their new host cells. These data are a formal demonstration that a transferred molecule may send signals to its new host cell. We also provide evidence that sensitivity to modulatory molecules can be acquired from other cells and introduce the notion of intercellular transfer of sensitivities.

Citing Articles

Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer.

Zeller T, Munnich I, Windisch R, Hilger P, Schewe D, Humpe A Front Immunol. 2023; 14:1240275.

PMID: 37781391 PMC: 10533923. DOI: 10.3389/fimmu.2023.1240275.


Activation and regulation of alloreactive T cell immunity in solid organ transplantation.

Duneton C, Winterberg P, Ford M Nat Rev Nephrol. 2022; 18(10):663-676.

PMID: 35902775 PMC: 9968399. DOI: 10.1038/s41581-022-00600-0.


NK Cells Acquire CCR5 and CXCR4 by Trogocytosis in People Living with HIV-1.

Vo D, Leventoux N, Campos-Mora M, Gimenez S, Corbeau P, Villalba M Vaccines (Basel). 2022; 10(5).

PMID: 35632444 PMC: 9145773. DOI: 10.3390/vaccines10050688.


HLA-G and Other Immune Checkpoint Molecules as Targets for Novel Combined Immunotherapies.

Morandi F, Airoldi I Int J Mol Sci. 2022; 23(6).

PMID: 35328349 PMC: 8948858. DOI: 10.3390/ijms23062925.


Inhibition of iNKT Cells by the HLA-G-ILT2 Checkpoint and Poor Stimulation by HLA-G-Expressing Tolerogenic DC.

Wu C, Caumartin J, Amodio G, Anna F, Loustau M, Gregori S Front Immunol. 2021; 11:608614.

PMID: 33505397 PMC: 7832389. DOI: 10.3389/fimmu.2020.608614.